While further studies are needed, including studies of polymorphisms in the cytochrome P450 1A1 (CYP1A1) gene [32] (likely a confounding factor when studying the associations between PCBs and BC risk), these data are not reassuring. This evidence concerns the gene CYP1A1 and breast cancer.